Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients
1 other identifier
interventional
86
1 country
1
Brief Summary
86 patients were randomized into hot-CHIVA (n=43) and control (n=43) groups. Study group patients had undergone radiofrequency ablation (RFA) VNUS Closure - FastTM of one segment of GSV close to saphenofemoral junction. Controls had undergone whole refluxing trunk ablation. Additional phlebectomy was performed in all the patients of both groups. Primary end-point was change in quality of life (QoL) measured with CIVIQ-20 at 12 months. Secondary end-points was recurrence of varicose veins at 12 months. The investigators also measured GSV caliber at the median and distal thigh change in hot-CHIVA group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2022
CompletedFirst Submitted
Initial submission to the registry
May 3, 2022
CompletedFirst Posted
Study publicly available on registry
May 12, 2022
CompletedMay 19, 2022
November 1, 2019
10 months
May 3, 2022
May 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life (QoL) was measured by ChronIc Venous Insufficiency Quality of Life (CIVIQ-20)
There are 20 questions in the CIVIQ-20, each with 5 possible answers (1 to 5), the minimum possible score being 20 and the maximum 100. In order to calculate the GIS, the difference between the final score and the minimum possible score is to be divided by the difference between the theoretical maximum and minimum scores (100-20=80), multiplied by 100.
12 months
Secondary Outcomes (3)
Varicose veins recurrence
12 months
Leg discomfort related to CVD symptoms measured with 10-cm visual analogue scale (VAS) at 3 months
2nd day, 7th day, 1 months, 3 months
In a study group remained GSV trunk diameter at mid- and lower thigh was measured at 1, 3, 6, 12 months after procedure
1 months, 3 months, 6 months, 12 months
Study Arms (2)
CHIVA group
EXPERIMENTAL43 participants. In the study group patients GSV was punctured 20-25 cm below SFJ. Radiofrequency catheter (ClosureFast) was inserted and positioned at SFJ distally to the superficial iliac circumflex vein. Four cycles were used for one segment below SFJ. After that catheter cooled down to 40C and was extracted. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.
Control group
ACTIVE COMPARATOR43 participants. In the controls GSV was punctured at a distal part of a refluxing segment. Catheter was positioned at SFJ and conventional radiofrequency procedure was performed with four cycles below SFJ and two cycles for every next segment. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.
Interventions
Radiofrequency ablation with concomitant phlebectomy
Eligibility Criteria
You may qualify if:
- C2EpAsPrGSVa, C2,3EpAsPrGSVa
- Reflux not lower than upper part of the calf,
- Age more than 18 years,
- SFJ diameter less than 15mm,
- Incompetence of terminal-femoral valve,
- GSV reflux more than 0,5 sec,
- re-entry perforator on the thigh or upper part of the calf for patients in the hot-CHIVA group
You may not qualify if:
- C4-C6 class of CEAP
- Pregnancy
- Deep vein reflux more than 1 sec
- SSV reflux more than 0,5 sec
- Those unwilling to sign an informed consent were also included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Veronika Golovina
Moscow, 109044, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2022
First Posted
May 12, 2022
Study Start
November 1, 2019
Primary Completion
September 1, 2020
Study Completion
February 27, 2022
Last Updated
May 19, 2022
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share